Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cipolla

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 12, 2022
Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial HypertensionMichel R Corboz, Adam J Plaunt, Vladimir S Malinin, et al.
Prostaglandins & Other Lipid Mediators|October 4, 2020
Prostanoid receptor subtypes involved in treprostinil-mediated vasodilation of rat pulmonary arteries and in treprostinil-mediated inhibition of collagen gene expression of human lung fibroblastsMichel R Corboz, William Salvail, Sandra Gagnon, et al.
ERJ Open Research|February 22, 2021
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitilRichard W Chapman, Michel R Corboz, Carlos Fernandez, et al.
Respiratory Research|May 17, 2023
Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trialDavid Cipolla, Jimin Zhang, Brice Korkmaz, et al.
Pharmacological Reviews|January 6, 2022
Inhaled Medicines: Past, Present, and FutureSandra Anderson, Paul Atkins, Per Bäckman, et al.
Pharmaceutics|September 28, 2023
Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA InfectionDonna M Konicek, Adam J Plaunt, Sachin Gharse, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 19, 2016
Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM WorkshopNicolas Roche, Gerhard Scheuch, John N Pritchard, et al.
AAPS Pharmscitech|April 24, 2008
Minimizing variability of cascade impaction measurements in inhalers and nebulizersMatthew Bonam, David Christopher, David Cipolla, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 8, 2025
Inhalable and Nasal Biologics: Analytical, Formulation, Development, and Regulatory ConsiderationsDavid Cipolla, Christopher J Gruenloh, Nani Kadrichu, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 27, 2020
Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking GroupJolyon P Mitchell, Ariel Berlinski, Sebastian Canisius, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|December 12, 2022
Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial HypertensionMichel R Corboz, Adam J Plaunt, Vladimir S Malinin, et al.
Prostaglandins & Other Lipid Mediators|October 4, 2020
Prostanoid receptor subtypes involved in treprostinil-mediated vasodilation of rat pulmonary arteries and in treprostinil-mediated inhibition of collagen gene expression of human lung fibroblastsMichel R Corboz, William Salvail, Sandra Gagnon, et al.
ERJ Open Research|February 22, 2021
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitilRichard W Chapman, Michel R Corboz, Carlos Fernandez, et al.
Respiratory Research|May 17, 2023
Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trialDavid Cipolla, Jimin Zhang, Brice Korkmaz, et al.
Pharmacological Reviews|January 6, 2022
Inhaled Medicines: Past, Present, and FutureSandra Anderson, Paul Atkins, Per Bäckman, et al.
Pharmaceutics|September 28, 2023
Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA InfectionDonna M Konicek, Adam J Plaunt, Sachin Gharse, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 19, 2016
Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM WorkshopNicolas Roche, Gerhard Scheuch, John N Pritchard, et al.
AAPS Pharmscitech|April 24, 2008
Minimizing variability of cascade impaction measurements in inhalers and nebulizersMatthew Bonam, David Christopher, David Cipolla, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 8, 2025
Inhalable and Nasal Biologics: Analytical, Formulation, Development, and Regulatory ConsiderationsDavid Cipolla, Christopher J Gruenloh, Nani Kadrichu, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 27, 2020
Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking GroupJolyon P Mitchell, Ariel Berlinski, Sebastian Canisius, et al.
Pageof 6